Home/Pipeline/Colovac

Colovac

Protection of colorectal anastomosis post-colectomy

Pivotal IDE StudyActive

Key Facts

Indication
Protection of colorectal anastomosis post-colectomy
Phase
Pivotal IDE Study
Status
Active
Company

About SafeHeal

SafeHeal is a French-American medtech company developing the Colovac device, an endoluminal bypass system designed to protect colorectal anastomoses and prevent dangerous post-surgical leaks. The company has achieved European MDR approval for Colovac and is conducting a pivotal IDE study in the U.S., having also received FDA Breakthrough Device designation. Led by an experienced CEO with a commercialization background, SafeHeal is positioned to address a significant unmet need in colorectal surgery recovery, aiming to improve patient outcomes and reduce the burden of temporary ostomies.

View full company profile

About SafeHeal

SafeHeal is a French-American medtech company developing the Colovac device, an endoluminal bypass system designed to protect colorectal anastomoses and prevent dangerous post-surgical leaks. The company has achieved European MDR approval for Colovac and is conducting a pivotal IDE study in the U.S., having also received FDA Breakthrough Device designation. Led by an experienced CEO with a commercialization background, SafeHeal is positioned to address a significant unmet need in colorectal surgery recovery, aiming to improve patient outcomes and reduce the burden of temporary ostomies.

View full company profile

Therapeutic Areas